Search research articles
Contact Us
Filters
Showing results (1-10 of 75) with videos related to
Page
of 8
Sort By:
The Physiologist
|
January 20, 2012
Summer research programs
Roy L Sutliff
Free Radical Biology & Medicine
|
May 9, 2012
HIV-1, reactive oxygen species, and vascular complications
Kristi M Porter, Roy L Sutliff
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research
|
June 6, 2008
The roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunction
Erik R Kline, Roy L Sutliff
American Journal of Respiratory Cell and Molecular Biology
|
March 12, 2020
Macrophage Signaling Pathways in Pulmonary Nontuberculous Mycobacteria Infections
Zohra Prasla, Roy L Sutliff, Ruxana T Sadikot
Antioxidants & Redox Signaling
|
December 25, 2018
Redox Biology of Peroxisome Proliferator-Activated Receptor-γ in Pulmonary Hypertension
Victor Tseng, Roy L Sutliff, C Michael Hart
Therapeutic Advances in Respiratory Disease
|
June 10, 2010
PPARgamma as a potential therapeutic target in pulmonary hypertension
Roy L Sutliff, Bum-Yong Kang, C Michael Hart
PPAR Research
|
August 22, 2007
The role of peroxisome proliferator-activated receptors in pulmonary vascular disease
Rachel E Nisbet, Roy L Sutliff, C Michael Hart
Pulmonary Circulation
|
May 7, 2011
Is peroxisome proliferator-activated receptor gamma (PPARγ) a therapeutic target for the treatment of pulmonary hypertension?
David E Green, Roy L Sutliff, C Michael Hart
American Journal of Physiology. Cell Physiology
|
May 11, 2012
Rosiglitazone attenuates NF-κB-mediated Nox4 upregulation in hyperglycemia-activated endothelial cells
Clintoria R Williams, Xianghuai Lu, Roy L Sutliff, et al.
Pulmonary Circulation
|
June 3, 2016
Proline-rich tyrosine kinase 2 downregulates peroxisome proliferator-activated receptor gamma to promote hypoxia-induced pulmonary artery smooth muscle cell proliferation
Kaiser M Bijli, Bum-Yong Kang, Roy L Sutliff, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 75) with videos related to
Sort By:
Page
of 8
The Physiologist
|
January 20, 2012
Summer research programs
Roy L Sutliff
Free Radical Biology & Medicine
|
May 9, 2012
HIV-1, reactive oxygen species, and vascular complications
Kristi M Porter, Roy L Sutliff
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research
|
June 6, 2008
The roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunction
Erik R Kline, Roy L Sutliff
American Journal of Respiratory Cell and Molecular Biology
|
March 12, 2020
Macrophage Signaling Pathways in Pulmonary Nontuberculous Mycobacteria Infections
Zohra Prasla, Roy L Sutliff, Ruxana T Sadikot
Antioxidants & Redox Signaling
|
December 25, 2018
Redox Biology of Peroxisome Proliferator-Activated Receptor-γ in Pulmonary Hypertension
Victor Tseng, Roy L Sutliff, C Michael Hart
Therapeutic Advances in Respiratory Disease
|
June 10, 2010
PPARgamma as a potential therapeutic target in pulmonary hypertension
Roy L Sutliff, Bum-Yong Kang, C Michael Hart
PPAR Research
|
August 22, 2007
The role of peroxisome proliferator-activated receptors in pulmonary vascular disease
Rachel E Nisbet, Roy L Sutliff, C Michael Hart
Pulmonary Circulation
|
May 7, 2011
Is peroxisome proliferator-activated receptor gamma (PPARγ) a therapeutic target for the treatment of pulmonary hypertension?
David E Green, Roy L Sutliff, C Michael Hart
American Journal of Physiology. Cell Physiology
|
May 11, 2012
Rosiglitazone attenuates NF-κB-mediated Nox4 upregulation in hyperglycemia-activated endothelial cells
Clintoria R Williams, Xianghuai Lu, Roy L Sutliff, et al.
Pulmonary Circulation
|
June 3, 2016
Proline-rich tyrosine kinase 2 downregulates peroxisome proliferator-activated receptor gamma to promote hypoxia-induced pulmonary artery smooth muscle cell proliferation
Kaiser M Bijli, Bum-Yong Kang, Roy L Sutliff, et al.
Page
of 8